IL6 and COVID-19: These findings reinforce the notion that enhanced IL-6 production may indeed be associated with a worse prognosis of COVID-19, as the PDM patients evaluated herein produced higher levels of this cytokine non-diabetic COVID-19 patients and were more likely to experience severe outcomes.